Literature DB >> 9504791

Soluble intercellular adhesion molecule-1 in newborn infants.

I Phocas1, A Sarandakou, G Giannaki, A Malamitsi-Puchner, D Rizos, P A Zourlas.   

Abstract

UNLABELLED: The aim of this study was to evaluate the effect of increasing postnatal age on soluble intercellular adhesion molecule-1 (sICAM-1), a very early and sensitive marker of immune activation and response in the serum of newborn infants. Serum sICAM-1 was measured by EIA (T Cell Diagnostics) in 20 healthy adults (controls) and in 43 (24 females/19 males) healthy neonates, of whom 28 were full term, and 15 were born at a gestational age between 35 and 38 weeks of pregnancy, on the 1st, 5th and 30th day of life. Neonatal serum sICAM-1 values showed a very significant increase (P < 0.01) from the 1st day (137.3+/-62.0 ng/ml) to the 5th day (259.3+/-124.0 ng/ml) and then to the 30th day of life (415.0+/-114.0 ng/ml), being significantly lower on the 1st day (P < 0.01), whereas significantly higher on the 30th day of life (P < 0.05), than those in healthy adults (305+/-195 ng/ml). Serum sICAM-1 values on the 1st day of life depended on both the mode of delivery (significantly higher in neonates born vaginally) and the gestational age at birth (significantly lower in those born at a gestational age over 38 weeks). A significant strong correlation was found in sICAM-1 values between the 1st and the 5th day following delivery (rp = 0.77, P < 0.009).
CONCLUSION: The results of this study demonstrate a significant rise of serum sICAM-1 during the 1st month of life in healthy neonates suggesting a progressively increased activation of the neonatal immune system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504791     DOI: 10.1007/s004310050788

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

1.  Intercellular adhesion molecule (ICAM-1) response after major neonatal surgery.

Authors:  Hiroyuki Koga; Hiroyuki Kobayashi; Atsuyuki Yamataka; Geoffrey J Lane; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2005-10-20       Impact factor: 1.827

2.  Serum soluble vascular cell adhesion molecule-1 (VCAM-1) concentrations in children with reflux nephropathy.

Authors:  Kazuhiro Kaneyama; Hiroyuki Kobayashi; Atsuyuki Yamataka; Geoffrey J Lane; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

3.  Markers of endothelial cell activation in suspected late onset neonatal sepsis in Surinamese newborns: a pilot study.

Authors:  Niek B Achten; Matijs van Meurs; Rianne M Jongman; Amadu Juliana; Grietje Molema; Frans B Plötz; Rens Zonneveld
Journal:  Transl Pediatr       Date:  2019-12

4.  Inflammatory cytokines in newborn infants.

Authors:  A Sarandakou; G Giannaki; A Malamitsi-Puchner; D Rizos; E Hourdaki; E Protonotariou; I Phocas
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

5.  Soluble form of ICAM-1, VCAM-1, E- and L-selectin in human milk.

Authors:  K Xyni; D Rizos; G Giannaki; A Sarandakou; I Phocas; G Creatsas
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

6.  Elevated levels of serum sICAM-1 in asphyxiated low birth weight newborns.

Authors:  Saadat Huseynova; Nushaba Panakhova; Pusta Orujova; Safikhan Hasanov; Mehman Guliyev; Agil Orujov
Journal:  Sci Rep       Date:  2014-10-31       Impact factor: 4.379

7.  Biomarkers of endothelial dysfunction predict sepsis mortality in young infants: a matched case-control study.

Authors:  Julie Korol Wright; Kyla Hayford; Vanessa Tran; Gulam Muhammed Al Kibria; Abdullah Baqui; Ali Manajjir; Arif Mahmud; Nazma Begum; Mashuk Siddiquee; Kevin C Kain; Azadeh Farzin
Journal:  BMC Pediatr       Date:  2018-03-23       Impact factor: 2.125

8.  Serum concentrations of endothelial cell adhesion molecules and their shedding enzymes and early onset sepsis in newborns in Suriname.

Authors:  Rens Zonneveld; Rianne M Jongman; Amadu Juliana; Grietje Molema; Matijs van Meurs; Frans B Plötz
Journal:  BMJ Paediatr Open       Date:  2018-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.